abstract |
In some aspects, the present disclosure relates to recombinant adeno-associated viruses with unique tissue targeting capabilities. In some aspects, the present disclosure relates to gene transfer methods using recombinant adeno-associated viruses. In some aspects, the present disclosure relates to isolated AAV capsid proteins and isolated nucleic acids encoding the same. |